Katrin Preller received her M.Sc. (Neuropsychology and Clinical Psychology) from University of Konstanz, Germany. She joined the University of Zurich where she investigated the neurobiological long-term effects of cocaine, MDMA, and heroin use. After completing her PhD, she investigated the effects of psychedelics on self-perception and social cognition at the Neuropsychopharmacology and Brain Imaging Lab. She received a SNSF PostDoc mobility fellowship and worked at the Wellcome Trust Centre for Neuroimaging, UCL, London, and Yale University, New Haven. Subsequently, she was appointed as Junior Group Leader at the University of Zurich, and holds a position as Visiting Assistant Professor at Yale University.
Dr. Preller is a recipient of the Pfizer Research Award and the Swiss Society for Biological Psychiatry Young investigators award. Her group’s research focus is centered on the neurobiology and pharmacology of cognitive and emotional processes in health and disease using multi-modal behavioral, electrophysiological and neuroimaging techniques, the development of novel treatment approaches, and the interaction between pharmacological and non-pharmacological treatments.
uniMIND Symposium Topic: Neurobiological mechanisms of psychedelics and implications for psychedelic-assisted therapy